Kairax Filler Treatments in London

Facial volume can decline gradually with age, and many patients notice softened contours or deeper folds around the nose and mouth as a result. Kairax dermal filler is a hyaluronic acid dermal filler designed to help address these changes.

At our central London clinic, Kairax treatment is delivered as a considered, plan-led protocol. It may suit patients exploring options for fine lines, volume loss, or facial contouring, with suitability confirmed through individual consultation and clinical assessment.

Kairax Filler Treatments in London

Consultation and Pricing

Treatment suitability, the personalised plan, and final cost are confirmed during consultation and clinical assessment, reflecting anatomy, treatment scope, and product volume required.

The figures below are general market guidance only, based on publicly advertised prices reviewed on 7 July 2026 across 10 London clinics. They are not our clinic’s prices and treatment costs vary depending on individual requirements.

London market guide — Kairax Filler

  • 1ml syringe (Kairax Fine, Deep, or Sub-Q): about £275–£495
  • Two areas of the face: about £450–£850
  • Combined 2 ml protocol: about £700–£1,150
  • Course of treatment (multiple sessions): about £750–£1,350

Before and After Kairax Filler Treatment

Following treatment, many patients report an improvement in facial proportion, softened folds, and a smoother-looking contour in the treated area. Results vary between individuals, and photographs represent individual patient outcomes rather than a guaranteed result.

Any initial swelling generally settles within 1 to 3 weeks, at which point the appearance of the treated area tends to become clearer. Outcomes depend on anatomy, product volume, and the area treated.

Visible changes patients commonly report:

Before and After Kairax Filler Treatment

What is Kairax Filler?

Kairax is a hyaluronic acid-based dermal filler, CE-approved, and contains lidocaine to support comfort during injection. It is produced using a cross-linked gel process intended to give the product its viscoelasticity and even consistency.

The range includes Kairax Fine, Kairax Deep, and Kairax Sub-Q, each formulated for different depths and areas of the face, from finer lines to more structural volume support.

As a hyaluronic acid-based filler, it may support hydration in the treated area, and it sits alongside — rather than replaces — the skin’s own collagen and elastin networks.

Key characteristics of Kairax filler:

  • CE-approved and contains lidocaine for patient comfort
  • Available in three formulations: Fine, Deep, and Sub-Q
  • Supplied as a 1x1ml pre-filled syringe for precise placement
  • Formulated with a cross-linked structure associated with specific viscoelastic properties
  • May be dissolved using an appropriate agent where clinically indicated

The Kairax Filler Process: Step by Step

01

Initial Consultation

A face-to-face consultation explores your concerns, aesthetic goals, and relevant medical history to help assess suitability for the procedure.

02

Clinical Assessment and Planning

The treatment area is assessed for volume loss, skin quality, and anatomical considerations, informing personalised treatment planning.

03

Pre-treatment Preparation

The skin is cleansed and, where appropriate, a topical numbing product may be applied ahead of injection.

04

Treatment Delivery

Kairax is delivered by injection using a fine needle, with product volume and placement guided by the agreed treatment plan.

05

Aftercare and Recovery Guidance

Aftercare advice is provided at the end of the session to support a comfortable recovery in the days that follow.

  • Procedure time: 30–45 minutes
  • Recovery: Mild swelling, tenderness, or an occasional bruise may occur and typically settles within 3 to 5 days.

Benefits of Kairax Filler

Kairax offers a structured, plan-led approach to facial rejuvenation, using a hyaluronic acid dermal filler designed to help improve the appearance of volume loss and softened facial contours, without surgery.

For patients concerned with nasolabial folds, cheek volume, or lower-face refinement, Kairax can be tailored to a single area or combined across several areas of the face during one visit, depending on clinical assessment.

Key benefits associated with the treatment:

Kairax Filler Treatment Options

Option One: Targeted Single-Area Treatment

A focused 1ml syringe of Kairax for patients with a single, defined concern such as an isolated nasolabial fold or subtle lip enhancement, suited to those new to injectable aesthetics.

Option Two: Multi-Area Facial Plan

A broader treatment addressing two or more areas, such as cheeks and jawline, using Kairax Deep or Sub-Q to support overall facial contouring and firmness.

Option Three: Combined Protocol

A more comprehensive plan combining Kairax formulations across different depths, such as a Kairax Enhance 45-style multi-zone approach (advanced injectable protocol using a formula of 90 mg of Hyaluronic Acid (HA) and 4 mg of Polynucleotides (PN)), or alongside complementary facial treatments following assessment.

Summary of available treatment approaches:

  • Single-area Kairax filler for a defined concern
  • Multi-area facial planning using Kairax Deep or Sub-Q
  • Course-based treatment for patients requiring staged sessions
  • Combination protocols alongside anti-wrinkle treatment or a skin booster, where suitable

Why Choose Us?

Angelika brings over eight years of international medical experience to injectable treatment planning, combining technique with a structured approach to patient safety and consultation standards.

Her practice integrates internationally developed methods within UK certification and insurance standards, prioritising subtle, considered outcomes over fixed or formulaic protocols.

Every treatment plan follows individual clinical assessment, informed by anatomy, medical history, and realistic goals rather than a standard package.

What distinguishes our approach:

  • Over 8 years of international medical experience informing technique
  • Practice aligned with UK certification, insurance, and safety standards
  • GMC-registered prescribing support from Dr. Ivan where clinically required
  • Personalised treatment planning confirmed through clinical assessment

Disclaimer: Angelika is an aesthetic practitioner, not a medical doctor. Where prescription-only products are clinically appropriate, face-to-face consultation and prescribing are provided by GMC-registered prescriber Dr. Ivan. This treatment is available to patients aged 18 and over.

Frequently Asked Questions (FAQs)

Longevity varies by formulation, treatment area, and individual metabolism, so results vary between individuals. Kairax Fine tends to suit more mobile areas, while Kairax Deep and Sub-Q are formulated for structural zones that may show longer-lasting support. Your practitioner will discuss realistic expectations during consultation, and maintenance sessions may be considered over time.

As with any injectable treatment, it carries potential risks and considerations, including bruising, swelling, asymmetry, or, rarely, more serious complications affecting blood vessels. A thorough consultation helps assess suitability. Your practitioner will explain relevant considerations, aftercare, and what to do if you have concerns, before any session proceeds.

The volume required depends on the area treated, the degree of volume loss, and your aesthetic goals. Some patients need a single 1ml syringe, while others may benefit from treating multiple areas. Your practitioner will recommend an appropriate starting volume during consultation, favouring a conservative approach that can be reviewed at a later appointment.

Kairax is CE approved and contains lidocaine, which is intended to help reduce discomfort during injection. Most patients describe a brief stinging sensation rather than significant pain. A topical numbing product may also be used beforehand for additional comfort in more sensitive areas.

Downtime is generally minimal for most patients. Some experience temporary swelling, tenderness, or a bruise at the injection site, usually settling within 3 to 5 days. Many people resume normal activities the same day, though makeup application is typically advised to wait for a short period.

Kairax may suit adults concerned with volume loss, nasolabial folds, or reduced facial definition. Suitability depends on medical history, skin quality, and treatment goals, assessed during consultation. It may not be appropriate for pregnant or breastfeeding individuals, or those with certain underlying health conditions.

Initial volume is visible shortly after treatment, though swelling can temporarily affect appearance. As any swelling settles, the appearance of the treated area typically becomes clearer over 1 to 3 weeks. A follow-up review may help determine whether any refinement is appropriate.

It is often considered alongside other facial treatments, such as anti-wrinkle treatment or a polynucleotide-based skin booster, depending on individual goals. Sequencing and timing of any combined treatments are planned carefully during consultation, following a considered, staged approach.